Dr. Bret E. Friday
Claim this profileEssentia Health Cancer Center
About Bret E. Friday
Education:
- Graduated with an MD from the University of Minnesota Medical School, Twin Cities Campus, in 2007.
- Completed Residency in Radiation Oncology at the University of Minnesota Medical Center in 2012.
- Undertook a Fellowship in Brachytherapy at the University of Minnesota Medical Center in 2013.
Experience:
- Board Certified in Radiation Oncology by the American Board of Radiology.
- Has been practicing as a Radiation Oncologist at Essentia Health Cancer Center since 2013.
Area of expertise
Lung Cancer
Bret E. Friday has run 23 trials for Lung Cancer. Some of their research focus areas include:
Cancer
Bret E. Friday has run 21 trials for Cancer. Some of their research focus areas include:
Affiliated Hospitals
Essentia Health Cancer Center
Essentia Health Sandstone
Clinical Trials Bret E. Friday is currently running
Chemotherapy + Immunotherapy
for Esophageal and Gastric Cancer
This phase III trial compares the effect of modified fluorouracil, leucovorin calcium, oxaliplatin, and irinotecan (mFOLFIRINOX) to modified fluorouracil, leucovorin calcium, and oxaliplatin (mFOLFOX) for the treatment of advanced, unresectable, or metastatic HER2 negative esophageal, gastroesophageal junction, and gastric adenocarcinoma. The usual approach for patients is treatment with FOLFOX chemotherapy. Chemotherapy drugs work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Fluorouracil stops cells from making DNA and it may kill tumor cells. Leucovorin is used with fluorouracil to enhance the effects of the drug. Oxaliplatin works by killing, stopping, or slowing the growth of tumor cells. Some patients also receive an immunotherapy drug, nivolumab, in addition to FOLFOX chemotherapy. Immunotherapy may induce changes in body's immune system and may interfere with the ability of tumor cells to grow and spread. Irinotecan blocks certain enzymes needed for cell division and DNA repair, and it may kill tumor cells. Adding irinotecan to the FOLFOX regimen could shrink the cancer and extend the life of patients with advanced gastroesophageal cancers.
Recruiting
2 awards
Phase 3
2 criteria
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting
2 awards
Phase 3
19 criteria
More about Bret E. Friday
Clinical Trial Related
7 years of experience running clinical trials · Led 125 trials as a Principal Investigator · 50 Active Clinical Trials
Treatments Bret E. Friday has experience with
- Nivolumab
- Pembrolizumab
- Paclitaxel
- Carboplatin
- Fluorouracil
- Ipilimumab
Breakdown of trials Bret E. Friday has run
Lung Cancer
Cancer
Breast Cancer
Pancreatic Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Bret E. Friday specialize in?
Bret E. Friday focuses on Lung Cancer and Cancer. In particular, much of their work with Lung Cancer has involved Stage IV patients, or patients who are Stage III.
Is Bret E. Friday currently recruiting for clinical trials?
Yes, Bret E. Friday is currently recruiting for 50 clinical trials in Duluth Minnesota. If you're interested in participating, you should apply.
Are there any treatments that Bret E. Friday has studied deeply?
Yes, Bret E. Friday has studied treatments such as Nivolumab, Pembrolizumab, Paclitaxel.
What is the best way to schedule an appointment with Bret E. Friday?
Apply for one of the trials that Bret E. Friday is conducting.
What is the office address of Bret E. Friday?
The office of Bret E. Friday is located at: Essentia Health Cancer Center, Duluth, Minnesota 55805 United States. This is the address for their practice at the Essentia Health Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.